Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Health Catalyst, Inc. (HCAT)

Health Catalyst names Simeon Kohl CEO and president, succeeding Ben Albert

Neutral Impact 4 of 5 leadership Written later

Health Catalyst's Board appointed Simeon Kohl as Chief Executive Officer, President, and a Class III director, effective September 14, 2026. Ben Albert resigned as CEO, President, and director, effective September 13, 2026, and will serve as Chief Business Officer; the filing says his resignation is not the result of any disagreement with the Company.

Key points

  • Kohl's salary is $600,000, with an annual bonus target of 100% of base salary.
  • The Board plans to grant Kohl 2,747,385 restricted stock units, with 915,975 vesting on September 4, 2027.
  • Albert's salary as Chief Business Officer is $415,000, effective September 14, 2026.
  • The Board adopted the 2026 Employment Inducement Incentive Plan, reserving 2,747,385 shares without stockholder approval under Nasdaq Rule 5635(c)(4).

The filing

CompanyHealth Catalyst, Inc. (HCAT)
Form8-K, current report
Filed with the SECSep 8, 2026, 8:13 AM ET
Accession number0001636422-26-000104

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.